Ultra Supplement LLC: Drug Recall
Recall #D-1350-2022 · 07/21/2022
Class I: Dangerous
Recall Details
- Recall Number
- D-1350-2022
- Classification
- Class I
- Product Type
- Drug
- Recalling Firm
- Ultra Supplement LLC
- Status
- Terminated
- Date Initiated
- 07/21/2022
- Location
- Wilmington, DE, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 750 cartons
Reason for Recall
Marketed Without an Approved NDA/ANDA: Analytical testing showed the presence of tadalafil.
Product Description
SUSTANGO (Pendenadril Tytrate Blend) Capsules, 400 mg, 10-count blisters per carton, Formulated by: Male FX Labs, Bangor, ME, ASIN X0024468I9.
Distribution Pattern
Product was distributed nationwide in the USA via Amazon Marketplace on www.amazon.com.
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.